{"id":3490,"date":"2020-11-19T00:00:00","date_gmt":"2020-11-19T00:00:00","guid":{"rendered":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/11\/19\/group-based-lifestyle-intervention-cuts-progression-to-t2dm\/"},"modified":"2020-11-20T18:10:17","modified_gmt":"2020-11-20T18:10:17","slug":"group-based-lifestyle-intervention-cuts-progression-to-t2dm","status":"publish","type":"post","link":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/2020\/11\/19\/group-based-lifestyle-intervention-cuts-progression-to-t2dm\/","title":{"rendered":"Group-Based Lifestyle Intervention Cuts Progression to T2DM"},"content":{"rendered":"<h3>\n<p>High-risk individuals making modest changes in weight, physical activity had lower odds of progressing to type 2 diabetes<\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, Nov. 19, 2020 (HealthDay News) &#8212; A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals, according to a study published online Nov. 2 in <em>JAMA Internal Medicine<\/em>.<\/p>\n<p>Michael Sampson, M.D., from the Norfolk and Norwich University Hospital NHS Trust in the United Kingdom, and colleagues assessed whether a group-based lifestyle intervention (with or without trained volunteers with type 2 diabetes) reduced the risk for progression to type 2 diabetes in people at increased diabetes risk. Participants were randomly assigned to a control arm receiving usual care (178 individuals), a theory-based lifestyle intervention arm of six core and up to 15 maintenance sessions (INT; 424 individuals), or the same intervention with support from diabetes prevention mentors who were trained volunteers with type 2 diabetes (INT-DPM; 426 participants).<\/p>\n<p>The researchers found that a total of 156 participants progressed to type 2 diabetes: 22.8 percent receiving usual care, 13.7 percent receiving INT, and 15.0 percent receiving INT-DPM. For type 2 diabetes incidence, there was no significant difference seen between the intervention arms (odds ratio [OR], 1.14; 95 percent confidence interval [CI], 0.77 to 1.7; P = 0.51). However, each intervention arm was associated with significantly lower odds of type 2 diabetes (INT: OR, 0.54 [95 percent CI, 0.34 to 0.85; P = 0.01]; INT-DPM: OR, 0.61 [95 percent CI, 0.39 to 0.96; P = 0.033]; combined: OR, 0.57 [95 percent CI, 0.38 to 0.87; P = 0.01]). For all glycemic levels, ages, and social deprivation groups, the effect size was similar. Intervention costs per participant were low at $153.<\/p>\n<p>&#8220;We have now shown a significant effect in type 2 diabetes prevention, and we can be very optimistic that even a modest weight loss, and an increase in physical activity, in real-world programs like this have a big effect on the risk of getting type 2 diabetes,&#8221; Sampson said in a statement.<\/p>\n<p>One author disclosed receiving personal fees from WW UK.<\/p>\n<p><a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2772239?resultClick=3\" target=\"_blank\" rel=\"noopener noreferrer\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener noreferrer\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>High-risk individuals making modest changes in weight, physical activity had lower odds of progressing to type 2 diabetes<\/p>\n","protected":false},"author":4,"featured_media":3691,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[85],"tags":[89],"acf":[],"_links":{"self":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/3490"}],"collection":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/comments?post=3490"}],"version-history":[{"count":0,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/posts\/3490\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media\/3691"}],"wp:attachment":[{"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/media?parent=3490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/categories?post=3490"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-34-224-182-223.compute-1.amazonaws.com\/dermatology.healthcare.pro\/index.php\/wp-json\/wp\/v2\/tags?post=3490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}